Real-Life Study in Diabetic Macular Edema
NCT05472376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 854
Last updated 2022-07-25
Summary
The goal of this study is to evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in diabetic macular edema (DME) patients.
Conditions
Interventions
- OTHER
-
Retrospective study
Retrospective study
Sponsors & Collaborators
-
Kocaeli University
lead OTHER
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-29
- Primary Completion
- 2022-03-17
- Completion
- 2022-06-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
The Course of Response to Focal Photocoagulation for DME
NCT00442156 ·Status: COMPLETED
-
Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema
NCT05343156 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Injections of Ziv-aflibercept for Macular Diseases
NCT02556723 ·Status: COMPLETED ·Phase: NA
-
Triple Therapy for Diffuse Diabetic Macular Edema
NCT01218750 ·Status: UNKNOWN ·Phase: NA
-
Imaging Parameters and DME Treatment Response
NCT02637245 ·Status: COMPLETED
-
Treatment of Refractory Diabetic Macular Edema With Infliximab
NCT00505947 ·Status: TERMINATED ·Phase: PHASE3
-
Brolucizumab Versus Aflibercept on Visual and Anatomical Outcomes in Diabetic Macular Edema
NCT07096713 ·Status: COMPLETED ·Phase: NA
-
Home Monitoring of Diabetic Macular Edema
NCT05223569 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Vitrectomy for Diabetic Macular Edema
NCT00709319 ·Status: COMPLETED
-
Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
NCT03453281 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
NCT02121262 ·Status: COMPLETED ·Phase: PHASE3
-
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
NCT06205979 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema
NCT06845163 ·Status: RECRUITING ·Phase: PHASE2
-
Laser and Medical Treatment of Diabetic Macular Edema
NCT00027287 ·Status: COMPLETED ·Phase: PHASE1
-
Describing Patient With DME, Their Patient Journey and Disease Progression
NCT05966753 ·Status: COMPLETED
-
DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact
NCT00789477 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
NCT05712720 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA
NCT03246152 ·Status: COMPLETED ·Phase: PHASE4
-
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
NCT04359771 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
NCT05759884 ·Status: UNKNOWN ·Phase: NA
-
The Study to YD312 Tablet in Patients With Diabetic Macular Edema
NCT03635814 ·Status: UNKNOWN ·Phase: PHASE2
-
Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)
NCT01512966 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of RC28-E Injection in Diabetic Macular Edema
NCT04782115 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema
NCT06179030 ·Status: COMPLETED
-
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema
NCT03927690 ·Status: COMPLETED ·Phase: PHASE2